SVA

Sinovac Biotech, Ltd
SVA

Overview Fund Trends Analyst Outlook Journalist POV
Delisted

SVA was delisted on the 22nd of February, 2019.

Back to rankings

29 hedge funds and large institutions have $961M invested in Sinovac Biotech, Ltd in 2023 Q2 according to their latest regulatory filings, with 25 funds opening new positions, increasing their positions, 1 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

more funds holding

Funds holding: →

more capital invested

Capital invested by funds: $ → $

more funds holding in top 10

Funds holding in top 10: →

less repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

Holders
29
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
3
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$1.54M
2
+$1.04M
3
+$291K
4
Skandinaviska Enskilda Banken (SEB)
Skandinaviska Enskilda Banken (SEB)
Sweden
+$259K
5
Geode Capital Management
Geode Capital Management
Massachusetts
+$179K

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$615M
2
$340M
3
$2.04M
4
$1.54M
5
$1.04M
6
$291K
7
$259K
8
$179K
9
$106K
10
$58.8K
11
$29.5K
12
$19.4K
13
$10.7K
14
$2.67K
15
$699
16
$336